The era of molecular hematopathology: Back to the future Editorial


Authors: Mroz, P.; Ewalt, M. D.; Harley, S. E.; Tsang, P. C.; Xian, R. R.; Soderquist, C. R.; Behdad, A.; Chung, B. M. Y.; Conant, J.; Fisher, K. E.; Nardi, V.; on behalf of the Association for Molecular Pathology Hematopathology Subdivision Leadership
Title: The era of molecular hematopathology: Back to the future
Keywords: treatment response; promoter region; somatic mutation; molecular genetics; editorial; cytogenetics; drug design; mutational analysis; proteomics; transcriptomics; hematologic malignancy; artificial intelligence; genomics; clinical decision making; hematology; enhancer region; molecular pathology; bone marrow depression; molecular diagnosis; clinical outcome; adoption; machine learning; insulator element; cancer prognosis; high throughput sequencing; international prognostic scoring system; human; whole genome sequencing; treatment guideline; deep learning; gene editing; crispr-cas9 system; digital polymerase chain reaction; single cell rna seq; whole transcriptome sequencing; data clustering; methylomics; molecular hematopathology
Journal Title: Journal of Molecular Diagnostics
Volume: 26
Issue: 11
ISSN: 1525-1578
Publisher: Elsevier Science, Inc.  
Date Published: 2024-11-01
Start Page: 945
End Page: 949
Language: English
DOI: 10.1016/j.jmoldx.2024.06.011
PROVIDER: scopus
PUBMED: 39461758
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark David Ewalt
    32 Ewalt